Author:
Foote MaryAnn,Morstyn George
Reference105 articles.
1. Asano S. Human granulocyte colony-stimulating factor: its basic aspects and clinical applications. Am J Ped Hematol/Oncol 1991;13:400–413.
2. Asano S, Sato N, Mori M, et al. Detection and assessment of human granulocyte-macrophage colony-stimulating factor (GM-CSF) producing tumours by heterotransplantation into nude mice. Br J Cancer 1980;41:689–694.
3. Azuma J, Kurimoto T, Awata S, et al. Phase I study of KRN8601 (rhG-CSF) in normal healthy volunteers: safety and pharmacokinet-ics in single subcutaneous administration. Rinsho Iyaka 1989;5: 2231–2252.
4. Bacigalupo A, Hows J, Gluckman E, et al. Bone marrow transplantation (BMT) versus immunosuppression for treatment of severe aplastic anemia (SAA): a report of the EBMT SAA Working Party. Br J Haematol 1988;70:177–182.
5. Bessho M, Toyoda A, Itoh N, et al. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor (rhGCSF) and erythropoietin (rhEPO) in severe aplastic anemia. Br J Haematol 1992;80:409–411.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献